Similarly to HSP70s, HSP47 has also been reported as a novel glioma-associated antigen for vaccination, since GBM patients with a positive cytotoxic T lymphocyte response to HSP47 showed a prolonged PFS and OS [159]. Here, SERPINH1 is linked to glioblastoma.